BDTX blackdiamondtherapeutics.com Net earnings per share growth forecast for next year

Corporate company logo of Black Diamond Therapeutics, Inc (BDTX)

The lack of commercial cash flow and the current testing stage create potential for a sharp surge in quotes for Black Diamond (BDTX). The history of consensus earnings estimates for the coming year visualizes these expectations, where -33.40 reflects the latest value of the metric. Growth is based on the expansion of MasterKey drugs and the application of the MAP platform to combat hidden mutations in cancer cells.

BDTX: Black Diamond Therapeutics, Inc. Net earnings per one share growth forecast for next year 07/04/2022 - 11/15/2026

Financial and market metric breakdowns for Black Diamond Therapeutics (BDTX)

Fundamental company analysis:Black Diamond Therapeutics, BDTX
Brand item of blackdiamondtherapeutics.com

The specifics of Black Diamond (BDTX) oncology pharmaceuticals make the business independent of macro cycles, tying the company's value to the success of clinical trials. This indicator measures the consensus earnings growth forecast for the coming year, reflecting the trend of analysts revising fundamental valuations. Rising values signal improving R&D prospects, while inflated expectations warn of the risk of overpayment. By analyzing the projected EPS growth rate, an investor determines whether the current market valuation is justified.

Competing companies

GMAB (Genmab Corp) - Earnings growth forecast for next year|Earnings growth forecast for next year exelixis.com|Net earnings per share growth forecast for next year Nuvalent (NUVL)|KYMR (Kymera) - Expected earnings per share trend next year|Earnings growth forecast for next year IDYA (IDEAYA Biosciences Inc)|Net earnings per one share growth forecast for next year Enliven Pharma|ORIC Pharmaceuticals Inc - Earnings growth forecast for next year|Expected net earnings per share growth next year Relay Therapeutics, Inc.|NRIX (Nurix Therapeutics) - Expected earnings per share growth for next year|TYRA: Projected earnings per share increase next year|VSTM (verastem.com) - Earnings growth forecast for next year|Expected net earnings per share growth next year Monte Rosa Tx GLUE|Earnings growth forecast for next year CGEM|Immuneering - Projected earnings per share growth rate for next year|C4 Therapeutics - Expected earnings per share growth for next year|Expected earnings per share trend next year RPTX|PMVP: Expected earnings per share growth for next year|karyopharm.com - Projected earnings per share increase next year|PPCB: Earnings growth forecast for next year|Bio Green Med Solution Inc - Expected earnings per share trend next year|AADI (Aadi Bioscience Inc) - Earnings growth forecast for next year|Expected net earnings per share growth next year aileronrx.com ALRN|Net earnings per share growth forecast for next year Blueprint Medicines Corp. (BPMC)|GLYC (GlycoMimetics) - Expected earnings per share trend next year|Earnings growth forecast for next year SWTX (SpringWorks Therapeutics, Inc)